Search Results
Jul 13, 2026, 08:30 ET Servier completes the acquisition of Edgewise Therapeutics' Muscular Dystrophy Business
dystrophy. BMD is a rare, X-linked genetic disorder that causes progressive muscle loss, with currently no approved treatment for patients. The loss of muscle function is irreversible and impacts patients' abilities to perform everyday activities like walking. DMD is a more severe, recessive X-linked genetic,
More news about: Servier
Jul 13, 2026, 08:30 ET Reduce Recruitment Risk by Understanding Patient Decisions, Upcoming Webinar Hosted by Xtalks
https://xtalks.com/partner-with-us/Contact:Soumya ShashikumarTel: +1 (416) 977-6555 x371Email: [email protected]
More news about: Xtalks
Jul 13, 2026, 08:30 ET Streamline Targeted LNP Development to Improve Preclinical Translation, Upcoming Webinar Hosted by Xtalks
https://xtalks.com/partner-with-us/Contact:Vera KovacevicTel: +1 (416) 977-6555 x371Email: [email protected]
More news about: Xtalks
Jul 13, 2026, 08:30 ET Edgewise Therapeutics Completes Sale of Sevasemten for Up to $2.65 Billion, Strengthening Balance Sheet and Centering Company Focus on Cardiovascular Pipeline
Becker and Duchenne muscular dystrophy. If approved, sevasemten would be the first therapy indicated for Becker muscular dystrophy, a rare, genetic, X-linked neuromuscular disorder that predominantly affects males and for which approximately 12,000 individuals are affected in the U.S., EU-5, and Japan.Sevasemten
More news about: Edgewise Therapeutics
Jul 13, 2026, 08:30 ET LEIFRAS Co., Ltd. Forms Strategic Alliance with HR Produce, Leveraging Its Network of Over 10,000 Preschools to Accelerate Expansion into Japan's Preschool Market
frontline staff, and parents.1. Integrating Milabo to Visualize Early Childhood DevelopmentMilabo is Leifras' proprietary Education X Technology platform that quantifies children's non-cognitive life skills, such as leadership, cooperation, and manners, backed by data analytics from
More news about: LEIFRAS Co., Ltd.
Jul 13, 2026, 08:30 ET Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 5.77 Million Tokens, and Total Crypto and Total Cash Holdings of $11.3 Billion
launched MAVAN (Made-in America VAlidator Network), a dedicated staking infrastructure for Bitmine assets, in 2026.For additional details, follow on X:
More news about: Bitmine Immersion Technologies, Inc.
Jul 13, 2026, 08:30 ET Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 5.77 Million Tokens, and Total Crypto and Total Cash Holdings of $11.3 Billion
launched MAVAN (Made-in America VAlidator Network), a dedicated staking infrastructure for Bitmine assets, in 2026.For additional details, follow on X:
More news about: Bitmine Immersion Technologies, Inc.
Jul 13, 2026, 08:30 ET Bitmine Immersion Technologies (BMNR) anuncia que sus tenencias de ETH alcanzan los 5,77 millones de tokens
America VAlidator Network), una infraestructura de staking dedicada a los activos de Bitmine.Para detalles adicionales, síganos en X:
More news about: Bitmine Immersion Technologies, Inc.
Jul 13, 2026, 08:11 ET MDT Introduces TMR1228D Always-On High-Sensitivity Dual-Axis Magnetic Switch IC with MicroAmp-Level Power Consumption
intermittent sampling, delivering faster response and higher reliability for always-on sensing applications.The TMR1228D incorporates independent X- and Y-axis sensing channels with separate outputs, supporting industry-standard quadrature A/B signals for rotary and linear position, speed, and direction
More news about: MultiDimension Technology Co., Ltd.
Jul 13, 2026, 08:00 ET Introducing "Famously You," Serving Up a New Treat from Famous Amos with a Family-Friendly Variety Series Celebrating Authentic Individuality
Night Live cast member Rachel Dratch, actor Michael Urie from Apple TV's Shrinking, award-winning singer and actress Naturi Naughton-Lewis, 2x Top Chef winner Buddha Lo, actor Robert Ri'chard, and legendary tap dancer Savion Glover."My dad built Famous Amos on the belief that everyone
More news about: Ferrero North America
Jul 13, 2026, 08:00 ET Fuel Retailers Applaud Upcoming House Vote on Penny Legislation
X. Contact: Tiffany Wlazlowski Neuman, Vice President,
More news about: NATSO, Inc.
Jul 13, 2026, 08:00 ET Maruchan Teams Up with Global Anime Sensation Demon Slayer: Kimetsu no Yaiba for First-Ever Collaboration at San Diego Comic Con
Yaiba, blending traditional Japanese design cues with the aesthetic of the series. The fully immersive environment includes limited-edition Maruchan x Demon Slayer merchandise, such as t-shirts, hoodies, and keychains, interactive elements, including claw machines, character displays featuring Tanjiro,
More news about: Maruchan
Jul 13, 2026, 08:00 ET A Seegene lança o primeiro estudo clínico global do setor com um milhão de participantes para definir novos padrões de testes específicos para cada doença
https://mma.prnewswire.com/media/2960320/PNG__2022_Seegene_logo_rgb_1135x227_Logo.jpg
More news about: Seegene
Jul 13, 2026, 07:57 ET I-ON Digital Outlines Growth Roadmap: Positioning Banks for the Digital Asset Era While Putting Gold to Work
"Gold shouldn't sit inert, and neither should a bank's balance sheet." Carlos X. Montoya, Chairman and CEO, I-ON Digital Corp."The pieces are converging and comprehensive regulatory clarity is arriving. Institutional rails
More news about: I-ON Digital Corp. (OTCQB: IONI)
Jul 13, 2026, 07:30 ET Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2026 Financial Results
www.linkedin.com/company/zimmerbiomet or X at
More news about: Zimmer Biomet Holdings, Inc.
Jul 13, 2026, 07:30 ET Dario Expects Proprietary AI Engine DarioIQ™ to Increase Recurring Revenue from Existing Customers by 10-15%
member engagement, retention and clinical outcomes, DarioIQ has the potential to further boost the Company's proven return on investment ("ROI") of 2.5X to 5X across its programs.DarioIQ increases active member engagement by 40% and improved member retention by 20% through highly personalized interventions
More news about: DarioHealth Corp.
Jul 13, 2026, 07:12 ET ESGFIRE Publishes Pre-Listing Analysis on Alchemy Labs Inc. (TSXV: ALCH) Ahead of TSX Venture Exchange Debut
on the Company's own framing: differentiated advanced-materials defence IP often trades at roughly 5–10x revenue; were Crypsis and related technologies to reach CAD $40–50M in annual revenue, a 6–8x multiple would imply an enterprise value of approximately CAD $240–400M. That figure is explicitly illustrative
More news about: ESGFIRE
Jul 13, 2026, 07:00 ET Olive Garden Announces the Return of its Iconic Never-Ending Pasta Pass
X. Media ContactHailey Fitch(407) [email protected]
More news about: Olive Garden
Jul 13, 2026, 07:00 ET IsoEnergy Releases 2025 Sustainability Report Demonstrating Commitment to Responsible Growth
These mines are currently on standby, ready for rapid restart as market conditions permit, positioning IsoEnergy as a near-term uranium producer.X: @IsoEnergyLtd
More news about: IsoEnergy Ltd.
Jul 13, 2026, 06:59 ET Q32 Bio Announces Positive 36-Week Topline Results from Part B of the SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata
"SEC") filings, press releases, public conference call transcripts and webcast transcripts, as well as on X (formerly Twitter) and LinkedIn. The information that Q32 Bio posts on its website or on X or LinkedIn could be deemed to be material information. As a result, Q32 Bio encourages investors, the media
More news about: Q32 Bio
Jul 13, 2026, 06:30 ET Hut 8 Schedules Second Quarter 2026 Earnings Release and Conference Call
hut8.com/investors, and its social media accounts, including on X and LinkedIn. The Company uses its website and social media accounts as primary channels for disclosing key information to its investors, some of which
More news about: Hut 8 Corp.
Jul 13, 2026, 06:30 ET Collective Mining Expands Guayabales Through ANM-Granted Mining Titles Following Public Hearings
(@Ariski73) on XFollow Collective Mining (@CollectiveCNL) on X,
More news about: Collective Mining Ltd.
Jul 13, 2026, 04:56 ET Leads Biolabs Announces Multiple Studies Selected for ESMO 2026, Highlighting the Growing Global Competitiveness of Its Core Pipeline
potential overall survival (OS) benefit that simultaneously targets PD-L1 and the co-stimulatory receptor 4-1BB. Developed using Leads Biolabs' proprietary X-Body bispecific platform, Opamtistomig is designed to simultaneously block PD-1/L1 immune suppression and conditionally activate 4-1BB, an agonist pathway,
More news about: Leads Biolabs
Jul 13, 2026, 04:27 ET ALZpath Demonstrates Global Clinical Impact at AAIC 2026, with Proprietary pTau217 Antibody Anchoring 86 Presentations Demonstrating Clinical and Diagnostic Value Across the Translational Pipeline
LinkedIn, X, BlueSky, and
More news about: ALZpath, Inc.
Jul 13, 2026, 03:11 ET MDT Introduces TMR1228D Always-On High-Sensitivity Dual-Axis Magnetic Switch IC with MicroAmp-Level Power Consumption
intermittent sampling, delivering faster response and higher reliability for always-on sensing applications.The TMR1228D incorporates independent X- and Y-axis sensing channels with separate outputs, supporting industry-standard quadrature A/B signals for rotary and linear position, speed, and direction
More news about: MultiDimension Technology Co., Ltd.